Ligand id: 8866

Name: cebranopadol

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 28.26
Molecular weight 378.21
XLogP 5.96
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Cebranopadol is being evaluated as a pain relief medication in Phase III clinical trials in patients with cancer-associated pain. Phase II studies in other types of pain have been completed (click here to link to's list of Phase II cebranopadol (GRT6005) trials).